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Purpose: To evaluate the impact of preoperative patient characteristics and flow rate on failure, early postoperative complica-
tions, and voiding in patients who underwent transvaginal tension-free vaginal tape-obturator (TVT-O) treatment for un-
complicated stress urinary incontinence (SUI). 
Methods: We retrospectively reviewed patients who underwent TVT-O for SUI at 3 Italian centres. The exclusion criteria 
were predominant voiding and storage symptoms suggestive of detrusor overactivity, the presence of grade >1 urogenital pro-
lapse, previous pelvic radiotherapy or other clinical contraindications for surgical procedures, neurogenic bladder dysfunction, 
and collagen diseases. Multivariate logistic regression models were constructed to identify predictors of early voiding dysfunc-
tion after TVT-O.
Results: A total of 219 patients underwent TVT-O between January 2010 and December 2015. All patients received follow-up 
at 3, 6, and 12 months, and underwent a stress test, uroflowmetry, and bladder ultrasound to evaluate the postvoid residual 
volume. They also responded to the Urogenital Distress Inventory (UDI-6) questionnaire. The rates of persistent incontinence 
after TVT-O, postoperative complications, and satisfaction were 16.4% (36 of 219), 24.2% (53 of 219), and 86.3% (189 of 219), 
respectively. Nineteen patients (9.5%) experienced early voiding dysfunction. Based on an analysis of baseline characteristics, 
we determined that a cutoff value of 9.0 on the UDI-6 predicted postoperative SUI with 62% specificity, 72% sensitivity, and 
66% accuracy. In the multivariate logistic regression analysis, a preoperative UDI-6≥9.0 was an independent predictor of 
postoperative SUI. The predictors of complications were menopause (P = 0.04) and the preoperative UDI-6 score (P = 0.01). 
Conclusions: Menopause and UDI-6 scores could be prognostic factors for persistent SUI after TVT-O. Well-designed pro-
spective studies with a suitable number of patients are needed to corroborate our findings.
Keywords: Urinary Incontinence; Uretrhal Sling; Urinary Incontinence, Stress; Tension-Free Vaginal Tape; Urodynamics 
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INTRODUCTION
Stress urinary incontinence (SUI) is a debilitating condition 
with a negative impact on well-being due to sexual dysfunction, 
physical morbidity, and loss of independence, work, and social 
life. The diagnostic evaluation is based on a careful clinical his-
tory, voiding diaries, pad testing, and urodynamic studies [1].
 Midurethral slings (MUS) represent the gold standard for 
the treatment of uncomplicated female SUI [2-4]. The transob-
turator and retropubic approaches were found to be equally ef-
fective for the treatment of SUI [5]. Although the transient 
voiding dysfunction risk seems to be equivalent between those 
2 approaches, the long-term voiding dysfunction risk is lower 
in patients who undergo transobturator tape (TOT) treatment 
[6,7]. 
 Voiding dysfunction following MUS has been reported in 
between 1.6% and 39% of cases [8,9], and its management in-
cludes long-term intermittent self-catheterization, indwelling 
bladder catheter placement, and tape mobilization and division; 
these treatment strategies have important impacts on patients’ 
satisfaction.
 Age, severe preoperative urge urinary incontinence, and sur-
gical complications are risk factors for long-term sling failure 
[10]. 
 Preoperative urodynamic studies have a significant impact 
on the clinical diagnosis and the likelihood of additional post-
operative treatment [8], and it is mandatory to distinguish be-
tween complicated and uncomplicated cases of incontinence 
[11].
 Controversy exists regarding the preoperative risk factors for 
postoperative voiding dysfunction, and the impact of urody-
namic factors is still debated [9,10,12-15]. As the peak urinary 
flow rate is an independent predictive factor for urinary reten-
tion after tension-free vaginal tape procedures [13], patients 
with a low preoperative flow rate can safely receive tension-free 
vaginal tape-obturator (TVT-O) treatment [16]. 
 Furthermore, conflicting results were reported regarding 
predictors of sling failure [17-21], and sparse data exist on pre-
operative risk factors of persistent SUI after TOT [8].
 The aim of this study was to evaluate the impact of preopera-
tive patient characteristics and flow rate on the failure rate, early 
postoperative complications, and voiding in patients who un-
derwent TVT-O for uncomplicated SUI. 
MATERIALS AND METHODS
Patient Selection
We retrospectively reviewed consecutive patients who under-
went a TVT-O procedure for uncomplicated SUI at 3 Italian 
centres (Florence, Verona, and Catania) between January 2010 
and December 2015.
 The exclusion criteria were predominant voiding and storage 
symptoms suggestive of detrusor overactivity, based on an anal-
ysis of a bladder diary; the presence of grade >1 urogenital 
prolapse (according to the Baden and Walker classification 
[22]) beyond the hymen or symptomatic prolapse; previous 
pelvic radiotherapy or other clinical contraindications for surgi-
cal procedures; neurogenic bladder dysfunction; and collagen 
diseases. After receiving instructions and providing written in-
formed consent, all patients underwent a TVT-O procedure. 
Patient Evaluation
Before surgery, all patients underwent a comprehensive assess-
ment including a clinical history (especially for pelvic recon-
structive procedures or hysterectomy), a physical examination, 
pad usage analysis, and uroflowmetry (UFM) according to 
good urodynamic practices [21]. The Urogenital Distress In-
ventory (UDI-6), the International Consultation on Inconti-
nence Questionnaire Urinary Incontinence form, a bladder di-
ary, a visual analogue scale, demographic information, medical 
history, and symptoms of lower urinary tract and pelvic floor 
dysfunction were assessed before and after MUS surgery. Con-
servative measures, such as bladder retraining and/or pelvic 
floor physiotherapy, had been previously tried in all patients, 
but did not succeed.
 
Uroflowmetry
Noninstrumented UFM was performed before the procedure. 
All patients voided, with a comfortably full bladder, in sitting 
position into a gravimetric uroflowmeter (Danflow 1100, 
SynMed Medicinteknik AB, Silkeborg, Denmark). According to 
good urodynamic practices [21], peak flow rate (PFR), voided 
volume, and postvoid residual (PVR) volume were recorded.
Surgical Procedure
Surgery was performed using a TVT-O sling. All patients re-
ceived broad-spectrum intravenous antibiotic prophylaxis 1 
hour before surgery. The operations were performed as previ-
ously described [23,24]. All procedures were performed under 
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local analgesia with light sedation, and a cough stress test was 
performed intraoperatively to avoid postoperative voiding diffi-
culties. 
 Cystoscopy was performed in the operating room if visceral 
lesions were suspected, or during follow-up if the patient pre-
sented with postoperative moderate or severely irritative uri-
nary symptoms or recurrent urinary tract infections. 
 The MUS was adjusted using the cough stress test with an 
intravesical volume of 300 mL to prevent urinary leakage and 
to avoid overtension. Patients were discharged after 2 spontane-
ous micturition episodes with a PVR <100 mL. Patients were 
admitted overnight and discharged with 24 hours of oral antibi-
otics.
Follow-up After Surgical Procedure
All patients received follow-up at 3, 6, and 12 months and un-
derwent a stress test, UFM, and bladder ultrasound to evaluate 
the PVR volume. They also responded to the UDI-6 question-
naire. The patients were considered cured when there was no 
subjective or objective evidence of SUI. We defined successful 
SUI treatment as the loss of <200 mL of urine or the use of one 
pad per day, in addition to a negative stress test [20,21]. Early 
voiding dysfunction was considered to be present when the pa-
tient required catheterisation within 48 hours of the procedure 
[15]. The procedure was considered a failure when the cure cri-
teria were not achieved. The presence of complications, accord-
ing to the Clavien-Dindo classification [25], and the reopera-
tion rates were evaluated over the course of follow-up as sec-
ondary endpoints. Patient satisfaction after treatment was eval-
uated according to the Patients’ Global Impression of Change 
scale [26]. 
Statistical Analysis
Continuous variables are presented as median (interquartile 
range), and differences between groups were tested by the Stu-
dent independent t-test or the Mann-Whitney U-test depend-
ing on whether their distribution was normal, as tested by the 
Kolmogorov-Smirnov test. 
 Multivariate logistic regression models were constructed to 
identify predictive factors of early voiding dysfunction by in-
cluding all the collected variables. One thousand bootstrap 
resamples were used for all accuracy estimates and to reduce 
the overfit bias. Area under the curve values were also calculat-
ed to identify the UDI-6 cutoff score most suitable for predict-
ing postoperative SUI.
 All tests were conducted using IBM SPSS Statistics ver. 19.0 
(IBM Co., Armonk, NY, USA). For all statistical comparisons, 
P-values <0.05 were considered to indicate statistical signifi-
cance. 
RESULTS
A total of 219 patients underwent TVT-O between January 
2010 and December 2015. Their baseline characteristics are 
presented in Table 1. All patients completed follow-up as sched-
uled, at 3, 6, and 12 months. Their mean age was 59 years, with 
a median body mass index (BMI) of 27 kg/m2; 63.9% of the pa-
tients were in menopause. No patients underwent hormone re-
placement therapy. Table 2 shows the characteristics of the pa-
tients according to preoperative PFR.
 Diabetes and hypertension were present in 7.7% and 27.3% 
of the cases, respectively. We observed significant changes in 
the mean PFR (24.95 mL/sec vs. 30.34 mL/sec, P<0.05), mean 
PVR (40.85 mL vs. 7.37 mL, P<0.01), and mean UDI-6 score 
(9.47 vs. 1.36, P<0.01) after surgery. 
 Incontinence persisted after surgery in 16.4% (36 of 219) of 
the participants, while the satisfaction rate was 86.3% (189 of 
219). The postoperative complication rate was 24.2% (53 of 
219), including 41 cases of Clavien-Dindo classification grade I 
complications (18.7%) and 12 cases of Clavien-Dindo classifi-
Table 1. Baseline characteristics of patients (n=219)
Characteristic Value
Age (yr) 59 (50–67)
Body mass index (kg/m2) 27 (24–29)
Number of childbirth 2 (1–2)
Pad/day 3 (2–4)
Peak flow rate (mL/sec) 23.25 (18.15–31.37)
Postvoid residual (mL) 40.85 (37.85–45.22)
UDI-6 10 (6–12)
Menopause 140 (63.9)
Diabetes 17 (7.8)
Hypertension 60 (27.4)
Type of childbirth
   Normal
   Episiotomy
   Dystocic
   Laceration
145 (66.2)
20 (9.1)
21 (9.6)
33 (15.1)
Values are presented as median (interquartile range) or number (%).
UDI-6, Urogenital Distress Inventory.
www.einj.org    285
 Cocci, et al.  •  Predicting Factors of Transobturator Tape Failure in TVT-O Procedure INJ
Int Neurourol J 2017;21:282-288
cation grade II complications (5.5%). No major complications 
(Clavien-Dindo classification grade ≥III) were observed.
 In the multivariate logistic regression analysis, the preopera-
tive UDI-6 score (odds ratio [OR], 1.21; 95% confidence inter-
val [CI], 1.04–1.50; P=0.02) and menopause (OR, 6.19; 95% 
CI, 0.68–56.45; P=0.03) were independent predictors of failure 
after a TVT-O procedure (Table 3). 
 Based on a receiver operating characteristics analysis, we de-
termined that a cutoff value of 9.0 on the UDI-6 scale predicted 
postoperative SUI with 62% specificity, 72% sensitivity, and 
66% accuracy. In the multivariate logistic regression analysis, a 
preoperative UDI-6 score ≥9.0 (OR, 2.81; 95% CI, 0.96–8.22; 
P=0.04) was an independent predictor of postoperative SUI. 
The only predictors of complications were menopause (OR, 
6.44; 95% CI, 1.26–32.94; P=0.04) and the preoperative UDI-6 
score (OR, 1.23; 95% CI, 1.05–1.34; P=0.01). After surgery, 19 
patients (9.5%) experienced early voiding dysfunction. In the 
multivariate logistic regression analysis (adjusted for age, BMI, 
number of children, and the UDI-6 score), the preoperative 
PFR (OR, 0.98; P =0.62) and preoperative PVR (OR, 0.99; 
P=0.25) were not associated with early voiding dysfunction. 
DISCUSSION
MUS represent the gold standard treatment for SUI, with high 
rates of recovery of continence. Since transvaginal tape was in-
troduced in 1996, this procedure has become one of the most 
commonly used SUI treatments [21]. The TOT procedure ap-
pears to be associated with a lower incidence of postoperative 
Table 2. Characteristics of patients according to preoperative peak flow rate   
Characteristic
Qmax (mL/sec)
P-value
<15 (n=21) ≥15 (n=180)
Age (yr) 59.87 (53.83–72.76) 58.0 (50.48–65.93) 0.58
Body mass index (kg/m2) 27.34 (24.57–30.31) 26.56 (23.88–29.38) 0.43
Number of childbirth 2 (1–2) 2 (1–2) 0.47
Pad/day 3 (2–4) 3 (2–4) 0.42
Preoperative UDI-6 9.47 (7.5–13.0) 9.47 (9.0–11.0) 0.43
Preoperative voided volume 370.0 (318.5–408.52) -
Menopause 15 (71.4) 125 (69.4) 0.85
Type of childbirth
   Normal
   Episiotomy
   Dystocic
   Laceration
  
12 (57.1)
1 (4.8)
5 (23.8)
3 (14.3)
  
115 (63.9)
19 (10.6)
16 (8.9)
30 (16.7)
0.18
Postoperative PFR 30.34 (25.50–30.34) 30.34 (26.62–30.34) 0.68
Postoperative UDI6 1.36 (0–1.68) 1.36 (0–1.36) 0.89
Postoperative voided volume 329.16 (319.20–335.6) 329.16 (307.50–339.16) 0.35
Postoperative PFR–preoperative PFR 17.5 (15.17–22.09) 4.74 (-4.17 to 9.46) <0.01
Postoperative voided volume–preoperative voided volume -79.35 (-101.02 to -13.83) -79.35 (-128.14 to 59.62) 0.36
Values are presented as median (interquartile range) or number (%).   
Qmax, maximum flow rate; UDI-6, Urogenital Distress Inventory; PFR, peak flow rate.
Table 3. Multivariate logistic regression of predictive factors of 
failure of TVT-O
Variable OR (95% CI) P-value
Age (yr) 1.02 (0.94–1.10) 0.60
Body mass index (kg/m2) 1.17 (0.97–1.40) 0.09
Number of childbirth 0.62 (0.32–1.18) 0.15
Pad/day 1.12 (0.95–1.32) 0.18
Peak flow rate (mL/sec) 0.97 (0.90–1.04) 0.43
Postvoid residual (mL) 1.00 (0.99–1.01) 0.43
UDI-6 1.24 (1.04–1.50) 0.02
Menopause 6.19 (0.68–56.45) 0.03
Type of childbirth 1.64 (0.11–23.22) 0.72
TVT-O, tension-free vaginal tape-obturator; OR, odds ratio; CI, confi-
dence interval; UDI-6, Urogenital Distress Inventory.
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voiding dysfunction [27]. However, some patients may present 
voiding dysfunction after surgery. In fact, no standard defini-
tion exists of postoperative voiding dysfunction after anti-in-
continence surgery.
 The International Urogynecological Association/International 
Continence Society joint report on the terminology for female 
pelvic floor dysfunction defines voiding dysfunction as follows: 
“Voiding dysfunction, a diagnosis by symptoms and urodynamic 
investigations, is defined as abnormally slow and/or incomplete 
micturition. Hesitancy is a complaint of a delay in initiating mic-
turition. Slow stream is a complaint of urinary stream perceived 
as slower compared to previous performance or in comparison 
with others. Intermittency is a complaint of urine flow that stops 
and starts on one or more occasions during voiding. Feeling of 
incomplete (bladder) emptying is a complaint that the bladder 
does not feel empty after passing urine. PVR (urine volume) 
quote upper limits of normal of 50 or 100 mL” [28].
 The treatment of voiding dysfunction is still controversial 
and depends from the timing of onset. Several options can be 
used, including short- (up to 48 hours) or long-term self-cathe-
terisation, tape mobilisation (2.4% of cases), or tape loosening 
to achieve a more desirable tension without interfering with the 
urinary flow [29].
 In our study, we identified early voiding dysfunction in 19 of 
219 patients (9.5%) who underwent TVT-O and required ure-
thral catheterization within 24–48 hours after Foley catheter re-
moval. 
 Mutone et al. [15] demonstrated that, in 153 patients who 
underwent TVT, previous incontinence surgery and previous 
prolapse (P=0.08 and P=0.06) were associated with voiding 
dysfunction.
 Lucena et al. [13] reviewed 100 patients who underwent a 
retropubic MUS procedure. The univariate analysis demon-
strated that an abnormal PFR for voiding was associated with 
an increased risk of voiding dysfunction (P=0.046) and that 
women with a larger bladder capacity (490 mL vs. 457 mL, 
P=0.04) were slightly protected.
 Preoperative urodynamic assessments aim to confirm the di-
agnosis (in case of doubt), to demonstrate the mechanism(s), 
and to identify factors that may affect treatment outcomes. How-
ever, whether urodynamic assessments improve long-term out-
comes following surgery remains controversial, and there is a 
lack of high-level evidence to support the assertion that urody-
namic assessments can predict the complications of surgery [30].
 Some studies have demonstrated that preoperative urody-
namic findings, such as high preoperative PVR, low preopera-
tive PFR, and low detrusor pressure during a pressure-flow 
study, might predict postoperative voiding dysfunction after 
anti-incontinence surgery [31-33].
 Nevertheless, other studies have failed to demonstrate uro-
dynamic predictors of post-MUS voiding dysfunction. Chang 
et al. [34] postoperatively evaluated 449 patients who under-
went TOT. Preoperative urodynamic parameters did not dem-
onstrate reproducible predictors of voiding dysfunction. 
 In our study, the preoperative flow rate was not shown to be 
a potential risk factor for the occurrence of early voiding dys-
function after a TVT-O procedure. The postoperative inconti-
nence rate was 16.4%, the complication rate was 24.2%, and the 
satisfaction rate was 86.3%. 
 Serati et al. [16], in a prospective, multicentre, observational 
study of 191 women presenting with urodynamically proven 
pure SUI treated by TVT-O, documented that failure of a previ-
ous incontinence treatment procedure was the only indepen-
dent predictor of subjective recurrence of SUI (hazard ratio 
[HR], 4.4; P=0.009) or objective recurrence (HR, 3.7; P=0.02). 
 In our study, menopause and the UDI-6 score were the only 
preoperative risk factors for early TVT-O failure and early com-
plications. An interpretation of these findings could be related 
to the sensitivity of the lower urinary tract to estrogens due to 
its shared common embryological origin with the female geni-
tal tract [35]. Substantial hormonal changes happen at meno-
pause, with impacts on all oestrogen-sensitive tissues. In partic-
ular, oestrogens target the functional layers of the urethra (epi-
thelium, vasculature, connective tissue, and muscle) which are 
fundamental for maintaining continence. 
 However, some limitations should be addressed. First, the 
retrospective nature of the study should be considered. More-
over, we did not collect more details about diabetes, such as gly-
cated haemoglobin levels, which may be risk factors for incon-
tinence. 
 In conclusion, women suffering from uncomplicated SUI 
with a low preoperative flow rate can safely undergo TVT-O. 
The short-term treatment success rate was found to be high. 
Menopause and the UDI-6 score may be prognostic factors for 
persistent SUI after TVT-O. Well-designed prospective studies 
with a suitable number of patients are needed to corroborate 
our findings.
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